There has been a flurry of activities surrounding new research findings and commercial launch of NMN or nicotinamide mononucleotide supplements in recent weeks. In case you missed it, here is a round-up of NutraIngredients-Asia’s coverage on the much...
Australian life science company EZZ is seeing strong growth in China with its nicotinamide mononucleotide (NMN) and bone growth supplements, supported by the use of social commerce platforms Kuaishou and Pinduoduo.
Swiss start-up xLongevity is advocating the need to test the efficacy of nutrient supplementation and has started doing so in Asia, beginning with a nicotinamide adenine dinucleotide (NAD+) test currently offered in India.
Health & Happiness Group (H&H Group) says demand for its high-end adult nutrition brand Swisse Plus+, especially its nicotinamide adenine dinucleotide (NAD+) and liver health products, is key to the 37.4 per cent revenue jump for its adult nutrition...
Trigonelline, an alkaloid found in plants and animals, is found to be closely linked to muscle health, with low serum levels reported in seniors suffering from sarcopenia, new findings from a Nestle-funded study have shown.
The testing of 18 commercially available NMN (nicotinamide mononucleotide) supplements sold in Singapore found that most products did not meet label claims, and researchers have called for industry-wide effort in resolving the issue.
A 60-day trial in India found that taking nicotinamide mononucleotide (NMN) at 600mg per day is the optimal dose for boosting the body’s nicotinamide adenine dinucleotide (NAD+) level and physical performance.
NMN, an anti-aging ingredient, has been disallowed by FDA because of its prior investigation as a drug. The determination, which came as something of a surprise given the ingredient’s market history, has raised questions of fairness and transparency.
Nicotinamide adenine dinucleotide (NAD+) loss is more significant in middle-aged men than women, a study funded by China dietary supplement giant BYHEALTH and national R&D institutions has found.
This round-up of new scientific findings will look at how low NAD+ level is associated with anaemia in women, Mitsubishi Life Sciences’ NMN clinical study findings, and the benefits of vitamin E for exercise recovery and PCOS.
Nicotinamide mononucleotide (NNM) supplementation is safe and practical strategy to boost NAD+levels, which plays a crucial role in cell function, among healthy subjects.
Supplements that claim to boost the body’s level of nicotinamide adenine dinucleotide (NAD+), namely nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), are increasingly common in Asia’s dietary supplement market.
Entity Health has created a novel dietary supplement, in which the oxidised form of nicotinamide adenine dinucleotide, also known as NAD+, could be delivered in the form of sublingual wafers.
Next Miracle Nutrient is opening its first retail outlet in Hong Kong selling its nicotinamide mononucleotide (NMN) supplement, with the firm also hoping it will serve as an ‘experience centre’ to educate the public on NMN.
China’s consumers are increasingly aware of how nicotinamide adenine dinucleotide (NAD+) plays a role in health, and Chromadex believes this presents opportunities for its flagship product Tru Niagen.
Hong Kong-based start-up Supernine is planning to distribute its healthy ageing supplements and coffee products containing nicotinamide mononucleotide (NMN) into China and Singapore this year.
